David Marek
2019 - Axsome Therapeutics
In 2019, David Marek earned a total compensation of $3M as Chief Commercial Officer at Axsome Therapeutics.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Non-Equity Incentive Plan | $231,000 |
| Option Awards | $2,545,597 |
| Salary | $128,333 |
| Total | $2,969,931 |
Marek received $2.5M in option awards, accounting for 86% of the total pay in 2019.
Marek also received $65K in bonus, $231K in non-equity incentive plan and $128.3K in salary.
Rankings
In 2019, David Marek's compensation ranked 4,130th out of 13,971 executives tracked by ExecPay. In other words, Marek earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,130 out of 13,971 | 70th |
Division Manufacturing | 1,500 out of 5,701 | 74th |
Major group Chemicals And Allied Products | 526 out of 2,200 | 76th |
Industry group Drugs | 444 out of 1,886 | 77th |
Industry Pharmaceutical Preparations | 340 out of 1,398 | 76th |
Pay ratio
| David Marek's Pay | $2,969,931 |
|---|---|
| Median Employee's Pay | $166,021 |
| Pay Ratio | 18to 1 |
In 2019, the annual total compensation of David Marek was $2,969,931.
The annual total compensation of the median employee at Axsome Therapeutics was $166,021.
The ratio of David Marek's pay to the pay of median employee was therefore 18 to one.
Source: SEC filing on April 21, 2020.
Marek's colleagues
We found three more compensation records of executives who worked with David Marek at Axsome Therapeutics in 2019.